Role of cannabinoid receptors in the regulation of cardiac contractility during ischemia/reperfusion

被引:7
作者
Maslov, L. N. [1 ]
Lasukova, O. V.
Krylatov, A. V.
Hanus, L. O.
Pertwee, R.
Ivanchuk, I. I.
Crowford, D.
机构
[1] Russian Acad Med Sci, Inst Cardiol, Siberian Div, Tomsk, Russia
[2] Tomsk State Pedagog Univ, Tomsk, Russia
[3] Hebrew Univ Jerusalem, Dept Med Chem & Nat Prod, Jerusalem, Israel
[4] Univ Aberdeen, Dept Biomed Chem, Aberdeen, Scotland
[5] Siberian State Med Univ, Tomsk, Russia
[6] Tocris Cookson, Bristol, Avon, England
基金
俄罗斯基础研究基金会;
关键词
cannabinoid receptors; cardiac contractility; ischemia; reperfusion; isolated heart;
D O I
10.1007/s10517-006-0417-4
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
We studied the effect of selective ligands of cannabinoid (CB) receptors on contractility of isolated Langendorff-perfused rat heart under conditions of 45-min total ischemia and 30-min reperfusion. Perfusion with a solution containing selective CB receptor agonist HU-210 for 10 min before ischemia increased the severity of reperfusion contractile dysfunction. This drug decreased left ventricular developed pressure and maximum rates of contraction and relaxation, but had no effect on heart rate and end-diastolic pressure. The negative inotropic effect of the drug was transitory and disappeared after 5-min reperfusion. Pretreatment with selective CB1 receptor antagonist SR141716A and selective CB2 receptor antagonist SR144528 had no effect on heart rate and myocardial contractility during reperfusion. Our results indicate that stimulation of CB receptors can increase the degree of reperfusion-induced cardiac contractile dysfunction. However, endogenous cannabinoids are not involved in the development of myocardial contractile dysfunction during ischemia/reperfusion of the isolated heart.
引用
收藏
页码:557 / 561
页数:5
相关论文
共 11 条
[1]
Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle [J].
Bonz, A ;
Laser, M ;
Küllmer, S ;
Kniesch, S ;
Babin-Ebell, J ;
Popp, V ;
Ertl, G ;
Wagner, JA .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2003, 41 (04) :657-664
[2]
Bouaboula M, 1999, MOL PHARMACOL, V55, P473
[3]
DEBEIKI MA, 1998, NEW LIFE HEART
[4]
Cannabinoid receptors and their endogenous agonists [J].
Felder, CC ;
Glass, M .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1998, 38 :179-200
[5]
Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts [J].
Ford, WR ;
Honan, SA ;
White, R ;
Hiley, CR .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (05) :1191-1198
[6]
STEREOCHEMICAL EFFECTS OF 11-OH-DELTA-8-TETRAHYDROCANNABINOL-DIMETHYLHEPTYL TO INHIBIT ADENYLATE-CYCLASE AND BIND TO THE CANNABINOID RECEPTOR [J].
HOWLETT, AC ;
CHAMPION, TM ;
WILKEN, GH ;
MECHOULAM, R .
NEUROPHARMACOLOGY, 1990, 29 (02) :161-165
[7]
HOWLETT AC, 1998, HDB SUBSTANCE ABUSE, P113
[8]
Litvitskii P F, 2002, Patol Fiziol Eksp Ter, P2
[9]
Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats [J].
Mansbach, RS ;
Rovetti, CC ;
Winston, EN ;
Lowe, JA .
PSYCHOPHARMACOLOGY, 1996, 124 (04) :315-322
[10]
ENANTIOMERIC CANNABINOIDS - STEREOSPECIFICITY OF PSYCHOTROPIC ACTIVITY [J].
MECHOULAM, R ;
FEIGENBAUM, JJ ;
LANDER, N ;
SEGAL, M ;
JARBE, TUC ;
HILTUNEN, AJ ;
CONSROE, P .
EXPERIENTIA, 1988, 44 (09) :762-764